Two mTOR inhibitors, rapamycin and Torin 1, differentially regulate iron-induced generation of mitochondrial ROS

Area of Science:

• Neuroscience
• Molecular Biology
• Toxicology

Background:

• Gene-environment interactions are implicated in neurodegeneration.
• Iron overload is a potential risk factor for neurodegenerative diseases.
• Mechanisms of iron-induced neurotoxicity remain unclear.

Purpose of the Study:

• To investigate the effects of mechanistic target of rapamycin (mTOR) inhibition on iron-stressed human neuroblastoma cells.
• To compare the impact of two mTOR inhibitors, rapamycin and Torin 1, under varying iron concentrations.

Main Methods:

• Human neuroblastoma cells were exposed to different concentrations of iron.
• Cells were treated with either rapamycin or Torin 1, both inhibitors of mTOR.
• Cytotoxicity and mitochondrial reactive oxygen species (ROS) levels were measured.

Main Results:

• At low iron concentrations, both rapamycin and Torin 1 showed similar effects.
• At high iron concentrations, Torin 1 exacerbated iron-induced cytotoxicity, unlike rapamycin.
• Torin 1 treatment led to significantly higher mitochondrial ROS levels in iron-stressed cells.

Conclusions:

• mTOR inhibition may not be a protective strategy against iron-induced neurotoxicity.
• The specific mTOR inhibitor and iron concentration are critical factors in determining cellular response.
• Further research is needed to elucidate the complex role of mTOR in iron-related neurodegeneration.